AAM's VP Policy Craig Burton shares the release of the 2018 Generic Drug Access & Savings in the U.S. report, which focused this year on savings from patient utilization of generic drugs. The report highlights 3 important findings:
- 9 out of every 10 prescriptions in the U.S. are generic drugs
- 93% of generic prescriptions are filled for less than $20
- The average copay for patients using generic drugs is $6.06 (compared to a brand-name drug average of over $40)
Competition from generic drugs is a key component of containing drug costs. Craig also shares that this access and savings is in jeopardy as a result of imbalances in the marketplace, anti-competitive behaviors by some brand-name drug manufacturers and a policy miscues by federal and state policymakers centered around the lack of understanding around the generic drug market. To learn more, visit: http://www.RxAccessReport.us